Patients with hepatocellular carcinoma waiting for liver transplantation are commonly treated with locoregional treatments, such as TACE and ablation, to prevent tumor progression and dropout and to improve long-term outcome after transplantation. | A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation